Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | multiple interactions | ISO | Ogfod1 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of OGFOD1 mRNA] | CTD | PMID:22206623 | 1,2-dimethylhydrazine | decreases expression | ISO | Ogfod1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of OGFOD1 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | OGFOD1 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of OGFOD1 mRNA | CTD | PMID:20660070 | 17beta-estradiol | increases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Estradiol results in increased expression of OGFOD1 mRNA | CTD | PMID:31614463 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of OGFOD1 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of OGFOD1 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ogfod1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of OGFOD1 mRNA | CTD | PMID:21570461 | 2-hydroxypropanoic acid | decreases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of OGFOD1 mRNA | CTD | PMID:30851411 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Ogfod1 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of OGFOD1 mRNA | CTD | PMID:20188158 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of OGFOD1 mRNA | CTD | PMID:28959563 | afimoxifene | multiple interactions | ISO | OGFOD1 (Homo sapiens) | 6480464 | afimoxifene inhibits the reaction [Estrogens results in increased expression of OGFOD1 mRNA] | CTD | PMID:21233418 | aflatoxin B1 | increases expression | ISO | Ogfod1 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of OGFOD1 mRNA | CTD | PMID:19770486 | all-trans-retinoic acid | decreases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of OGFOD1 mRNA | CTD | PMID:33167477 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of OGFOD1 mRNA | CTD | PMID:30779732 | aristolochic acid A | increases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of OGFOD1 protein | CTD | PMID:33212167 | arsenous acid | decreases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of OGFOD1 mRNA | CTD | PMID:25555879 | arsenous acid | multiple interactions | ISO | OGFOD1 (Homo sapiens) | 6480464 | [Arsenic Trioxide co-treated with Ascorbic Acid] results in decreased expression of OGFOD1 mRNA | CTD | PMID:25555879 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of OGFOD1 mRNA | CTD | PMID:25181051 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of OGFOD1 gene | CTD | PMID:28505145 | cadmium atom | increases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Cadmium results in increased expression of OGFOD1 mRNA | CTD | PMID:24376830 | carbon nanotube | decreases expression | ISO | Ogfod1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | choline | multiple interactions | ISO | Ogfod1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of OGFOD1 mRNA | CTD | PMID:20938992 | cisplatin | decreases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of OGFOD1 mRNA | CTD | PMID:19561079 | coumestrol | increases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of OGFOD1 mRNA | CTD | PMID:19167446 | cyclosporin A | increases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of OGFOD1 mRNA | CTD | PMID:20106945 | diarsenic trioxide | decreases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of OGFOD1 mRNA | CTD | PMID:25555879 | diarsenic trioxide | multiple interactions | ISO | OGFOD1 (Homo sapiens) | 6480464 | [Arsenic Trioxide co-treated with Ascorbic Acid] results in decreased expression of OGFOD1 mRNA | CTD | PMID:25555879 | dorsomorphin | multiple interactions | ISO | OGFOD1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of OGFOD1 mRNA | CTD | PMID:29803840 | entinostat | decreases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | entinostat results in decreased expression of OGFOD1 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | OGFOD1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OGFOD1 mRNA | CTD | PMID:27188386 | epoxiconazole | decreases expression | ISO | Ogfod1 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of OGFOD1 mRNA | CTD | PMID:35436446 | ethanol | affects splicing | ISO | Ogfod1 (Mus musculus) | 6480464 | Ethanol affects the splicing of OGFOD1 mRNA | CTD | PMID:30319688 | folic acid | multiple interactions | ISO | Ogfod1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of OGFOD1 mRNA more ... | CTD | PMID:20938992 and PMID:22206623 | folic acid | increases expression | ISO | Ogfod1 (Mus musculus) | 6480464 | Folic Acid results in increased expression of OGFOD1 mRNA | CTD | PMID:25629700 | L-ascorbic acid | multiple interactions | ISO | OGFOD1 (Homo sapiens) | 6480464 | [arsenic trioxide co-treated with Ascorbic Acid] results in decreased expression of OGFOD1 mRNA | CTD | PMID:25555879 | L-ascorbic acid | decreases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Ascorbic Acid results in decreased expression of OGFOD1 mRNA | CTD | PMID:25555879 | L-methionine | multiple interactions | ISO | Ogfod1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of OGFOD1 mRNA | CTD | PMID:20938992 | lead(0) | decreases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Lead results in decreased expression of OGFOD1 mRNA | CTD | PMID:19921347 | maneb | multiple interactions | ISO | Ogfod1 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of OGFOD1 mRNA | CTD | PMID:36117858 | methotrexate | increases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Methotrexate results in increased expression of OGFOD1 mRNA | CTD | PMID:24449571 | methyl methanesulfonate | increases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of OGFOD1 mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of OGFOD1 mRNA | CTD | PMID:28001369 | nickel atom | decreases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Nickel results in decreased expression of OGFOD1 mRNA | CTD | PMID:25583101 | paracetamol | affects expression | ISO | Ogfod1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of OGFOD1 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of OGFOD1 mRNA | CTD | PMID:33387578 | paraquat | multiple interactions | ISO | Ogfod1 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of OGFOD1 mRNA | CTD | PMID:36117858 | perfluorohexanesulfonic acid | decreases expression | ISO | Ogfod1 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of OGFOD1 mRNA | CTD | PMID:37995155 | phenobarbital | affects expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of OGFOD1 mRNA | CTD | PMID:19159669 | progesterone | multiple interactions | ISO | OGFOD1 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of OGFOD1 mRNA | CTD | PMID:20660070 | rac-lactic acid | decreases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of OGFOD1 mRNA | CTD | PMID:30851411 | resveratrol | multiple interactions | ISO | OGFOD1 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of OGFOD1 mRNA | CTD | PMID:23557933 | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of OGFOD1 mRNA | CTD | PMID:28374803 | SB 431542 | multiple interactions | ISO | OGFOD1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of OGFOD1 mRNA | CTD | PMID:34492290 | trichostatin A | decreases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of OGFOD1 mRNA | CTD | PMID:24935251 | urethane | decreases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Urethane results in decreased expression of OGFOD1 mRNA | CTD | PMID:28818685 | valproic acid | decreases methylation | ISO | OGFOD1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of OGFOD1 gene | CTD | PMID:29154799 | valproic acid | affects expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of OGFOD1 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of OGFOD1 mRNA | CTD | PMID:23179753 and PMID:26272509 | valproic acid | multiple interactions | ISO | OGFOD1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OGFOD1 mRNA | CTD | PMID:27188386 | vitamin E | decreases expression | ISO | OGFOD1 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of OGFOD1 mRNA | CTD | PMID:19244175 | |